Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF)

Overview of attention for article published in JAMA Dermatology, January 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#42 of 4,363)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 68 news outlets
twitter: 16 X users

guideline: 2 clinical guideline sources
podcasts: 1 podcast

Readers on

mendeley: 61 Mendeley

So far, Altmetric has seen 68 news stories from 68 outlets.

Participant Motivations Key to Success in Clinical Trials

Dermatology Times, 31 Oct 2024

Image Credit: © toeytoey - stock.adobe.com Research engagement is essential to the success of randomized clinical trials (RCTs)…

Patient-Led Surveillance Safe, Feasible After Localized Melanoma Treatment

Medscape, 14 Dec 2021

(Reuters Health) - It may be safe and feasible for patients treated for localized melanoma to manage surveillance for future…

Skin cancer self-surveillance spots trouble

Mandurah Mail, 07 Dec 2021

Melanoma patients using their smart phone to submit images of lesions to their specialists appears to be a safe and convenient…

News story from Bunbury Mail on Tuesday 07 December 2021

Bunbury Mail, 07 Dec 2021

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 64 additional news stories.